Skip to main content

What's Best for Your Breasts


To test or not to test? Or more specifically, when to test? That's the crucial query. Last November, the U.S. Preventive Services Task Force (USPSTF) recommended that women swap their after-40 annual mammograms for biannual ones starting at 50, and quit breast self-exams altogether. It cited evidence that less frequent mammos could be equally effective at catching cancer. (Fewer tests would also save money, though the group insists it didn't consider cost.) Plus, the USPSTF argued, self-exams haven't been proven to reduce deaths but can lead instead to lots of unwarranted doctors' visits.

Keep yourself healthy with these free downloadable guides exclusively from Women's Health.

The screening revisions ignited a firestorm of controversy (after all,some 40,000 women die of breast cancer each year), thanks to conflicting data on mammogram efficacy. Current research hasn't yielded any hard conclusions, leaving patients confused and aggravated. "One disturbing aspect of the guidelines is that they're based on the idea that having a mammogram is anxiety provoking," says Karen L. Hiotis, M.D., a breast surgeon at the New York University Cancer Institute. "That's almost an insult to me as a woman."

Hiotis continues to favor self-exams and annual screenings for average-risk patients starting at age 40 (high-risk patients should start earlier). Yet she has noticed that fewer of her younger patients have booked mammos since the USPSTF recs were released. "Those happened to coincide with the recession, when more people were without work and health insurance," she says. "So, many thought it was OK to have fewer tests. I've spent the past year telling patients, no, it's not OK."

Help prevent cancer: Add these 13 superfoods to your diet.

The majority of breast docs agree, despite evidence that benign tumors are being misdiagnosed as cancer, sometimes resulting in unnecessary biopsies or mastectomies. The problem, notes the USPSTF, is that women under 50 tend to have denser breasts, making malignancies harder to spot. On the other hand, cancerous tumors in women under 50 can be much more lethal, and overlooking one could be a fatal mistake. "Ethically, you don't want to be a doctor who misses cancer," says Sharmila Makhija, M.D., the director of gynecologic oncology at the Emory University School of Medicine in Atlanta.

For its part, the American Cancer Society issued its own review in September, reinforcing 40 as the recommended age to begin annual mammos. The group neither endorsed nor discouraged self exams— essentially, it says, they won't hurt you, but they won't help you either. Hiotis disagrees. "I can't tell you the number of patients I see who have noted masses in their breasts themselves," she says. Adds Laura Lawson,M.D., a breast surgeon at Baptist Hospital in Nashville: "I have many breast-cancer patients in their twenties and thirties. And these are not women who were getting mammograms, so self examination is crucial."

Actress Christina Applegate talks about life after her breast cancer diagnosis and surgery.

The bottom line for now is that while mammos aren't perfect, they're the best breast-cancer detection we have. Research on new tests is in the works, and more precise digital mammogram technology is already out. Because the breast-care debate will likely wage on, it's up to you to be proactive and talk to your doctor about your individual risk, and to weigh the pros and cons of early testing. Lawson points out you can never be too careful: "For the person whose cancer is caught early, regular screening is lifesaving."

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis

  Introduction Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis. ...

Men With Breast Cancer Face Worse Prognosis

Men who are diagnosed with breast cancer are more likely than female patients to die in the next 15 years, researchers report. "This may be due to a difference in tumor characteristics and treatment," says study leader Hui Miao, a PhD candidate at the National University of Singapore. Male breast cancer is rare, accounting for less than 1% of all breast cancers in the U.S. Given its scarcity, few studies have assessed its prognosis "and we know of no recent studies looking at trends in survival," Miao tells WebMD. So Miao and colleagues studied 459,846 women and 2,664 men diagnosed with breast cancer in Denmark, Finland, Switzerland, Norway, Singapore, and Sweden between 1970 and 2007. Among the findings, presented at the San Antonio Breast Cancer Symposium: Men were diagnosed at an older age: 69 vs. 61 for women. Twice as many men had later stage III or IV disease: 18% vs. 9% of women. Only 25% of men were alive 15 years after diagnosis, compared with 44...